Darpö, Börje
138  results:
Search for persons X
?
1

Concentration‐QTcF Modeling of Icenticaftor from a Randomiz..:

Iyer, Ganesh R. ; Darpo, Borje ; Xue, Hongqi...
Clinical Pharmacology in Drug Development.  13 (2024)  5 - p. 572-584 , 2024
 
?
2

Virtual clinical QT exposure-response studies – A translati..:

Aguado-Sierra, Jazmin ; Dominguez-Gomez, Paula ; Amar, Ani...
Journal of Pharmacological and Toxicological Methods.  126 (2024)  - p. 107498 , 2024
 
?
4

Cardiovascular Evaluation of Etrasimod, a Selective Sphingo..:

Darpo, Borje ; Connor, Kalvin ; Cabell, Christopher H..
Clinical Pharmacology in Drug Development.  13 (2024)  4 - p. 326-340 , 2024
 
?
 
?
7

Concentration–QTc Relationship from a Single Ascending Dose..:

Fadiran, Emmanuel O. ; Hammond, Edward ; Tran, James...
Clinical Pharmacology in Drug Development.  12 (2023)  9 - p. 888-901 , 2023
 
?
 
?
10

The New S7B/E14 Q&A Document Provides Additional Opportunit..:

Darpo, Borje ; Leishman, Derek J.
The Journal of Clinical Pharmacology.  63 (2023)  11 - p. 1256-1274 , 2023
 
?
13

A Phase 1 Clinical Study Evaluating the Effects of Cenobama..:

Darpo, Borje ; Sager, Philip T. ; Xue, Hongqi.
Clinical Pharmacology in Drug Development.  11 (2022)  4 - p. 523-534 , 2022
 
?
14

Evaluation of Deutetrabenazine's Potential to Delay Cardiac..:

Schneider, Frank ; Darpo, Borje ; Loupe, Pippa S....
Clinical Pharmacology in Drug Development.  12 (2022)  1 - p. 94-106 , 2022
 
?
15

ECG Evaluation as Part of the Clinical Pharmacology Strateg..:

Darpo, Borje ; Borin, Marie ; Ferber, Georg...
The Journal of Clinical Pharmacology.  62 (2022)  12 - p. 1480-1500 , 2022
 
1-15